TCL Archive NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study. June 3, 2005
TCL Archive Two former Bristol-Myers Squibb executives were indicted as the company agreed to pay $300 million to investors. June 17, 2005
TCL Archive NCI To Fund Only 30-35% Of Approved Grants Even With $815 Million Construction Slashed August 20, 1976
TCL Archive New Drug Approval: Groups Urge FDA To Move Quickly On Herceptin Approval September 18, 1998
